Skip to main content
SpringerLink
Log in

Specific GI Microbial Infections

  • Chapter
  • First Online:
Pocket Handbook of GI Pharmacotherapeutics

Part of the book series: Clinical Gastroenterology ((CG))

Abstract

Specific GI infections encompass a broad range of bacteria, viruses, and other organisms which are often not considered normal flora. Many of these infections are seen in both healthy and immunocompromised individuals within the USA and abroad. This chapter will focus on specific pharmacotherapies, indication of treatment, and alternative drug regimens in resistant or recurrent infection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology Guideline on the management of helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–25.

    Article  CAS  PubMed  Google Scholar 

  2. Feldman M, et al. Sleisenger & Fordtran’s gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders; 2006.

    Google Scholar 

  3. Johnson S, Schriever C, Galang M, et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis. 2007;44:846.

    Article  CAS  PubMed  Google Scholar 

  4. Louie TJ, Miller MA, et al. Fidaxomicin versus Vancomycin for C.Diff Infection. N Engl J Med. 2011;364:422–31.

    Article  CAS  PubMed  Google Scholar 

  5. Cohen S, et al. Clinical practice guidelines for clostridium difficile infection in adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines. JSTOR. 2010. http://www.cdc.gov/HAI/pdfs/cdiff/Cohen-IDSA-SHEA-CDI-guidelines-2010.pdf. Accessed 31 Dec 2015.

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology & Hepatology, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT, 06030, USA

    Houman Rezaizadeh M.D.

  2. Gastroenterology-Hepatology Fellowship Program, University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT, 06030-1235, USA

    Erik Olson D.O.

Authors
  1. Houman Rezaizadeh M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erik Olson D.O.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Houman Rezaizadeh M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, Connecticut, USA

    George Y. Wu

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rezaizadeh, H., Olson, E. (2016). Specific GI Microbial Infections. In: Wu, G. (eds) Pocket Handbook of GI Pharmacotherapeutics. Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-33317-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33317-5_7

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-33315-1

  • Online ISBN: 978-3-319-33317-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation